Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010
Otter Lake Resources, Inc. New (NASDAQ: OTLK) Delayed: 0.64 -0.02 (3.03%)
Previous Close $0.66    52 Week High $0.03 
Open $0.66    52 Week Low $0.01 
Day High $0.67    P/E N/A 
Day Low $0.64    EPS $0.00 
Volume 2,935,701